The COVID-19 prophylactic vaccines are mainly based on the whole S glycoprotein subunit of SARS-CoV-2-Wuhan-1 due to its high antigenicity and immunogenicity [64,65,66,67,68,69,70]. The gene discussed is ART4; the disease is COVID-19.